Sign Up Today and Learn More About Yantai Lannacheng Biotechnology Stock
Invest in or calculate the value of your shares in Yantai Lannacheng Biotechnology or other pre-IPO companies through EquityZen's platform.
Yantai Lannacheng Biotechnology Stock (YALB)
Yantai Lannacheng Biotechnology is a biotech business that focuses on the building class I diagnosis medication.
About Yantai Lannacheng Biotechnology Stock
Founded
2021
Industries
Science and Engineering, Health Care, Biotechnology
Yantai Lannacheng Biotechnology Press Mentions
Stay in the know about the latest news on Yantai Lannacheng Biotechnology
Dual-targeting compound and preparation method and application thereof
patents • May 04, 2025
Compound targeting sstr2, preparation method therefor and use thereof
patents • Nov 04, 2024
Rgd dimer compound, and preparation method therefor and use thereof
patents • Nov 04, 2024
Dual-targeting compound for fibroblast activation protein (fap) and integrin …
patents • Sep 26, 2024
Dual-targeting compound and preparation method and application thereof
patents • Sep 26, 2024
Join now and verify your accreditation status to gain access to:
- Yantai Lannacheng Biotechnology Current Valuation
- Yantai Lannacheng Biotechnology Stock Price
- Yantai Lannacheng Biotechnology Management
- Available deals in Yantai Lannacheng Biotechnology and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Yantai Lannacheng Biotechnology Cap Table and Funding History by Share Class and Liquidity Preferences
- Yantai Lannacheng Biotechnology Revenue and Financials
- Yantai Lannacheng Biotechnology Highlights
- Yantai Lannacheng Biotechnology Business Model
- Yantai Lannacheng Biotechnology Risk Factors
- Yantai Lannacheng Biotechnology Research Report from SACRA Research
Trading Yantai Lannacheng Biotechnology Stock
How to invest in Yantai Lannacheng Biotechnology stock?
Accredited investors can buy pre-IPO stock in companies like Yantai Lannacheng Biotechnology through EquityZen funds. These investments are made available by existing Yantai Lannacheng Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Yantai Lannacheng Biotechnology stock?
Shareholders can sell their Yantai Lannacheng Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
